Possible reasons for the inefficacy of genetically engineered biological agents in rheumatoid arthritis and ways of its prevention
Genetically engineered biological agents (GEBAs) have held a firm place in the treatment of rheumatoid arthritis (RA). Patients are selected for this treatment in accordance with international and Russian guidelines. The question as to whether GEBAs should be added to therapy with disease-modifying...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2012-06-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/410 |